1-3
2026
影响因子区间
—
平台估算
32%
2025
中国作者发文占比
1500 EUR
收费
期刊简介:Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.Topics covered are:• drug design• molecular modelling/docking studies• pharmaceutical chemistry/medicinal chemistry• drug metabolism• analytics of drugs• pharmaceutical technology/formulation studies/nanosystems/cosmetology• pharmaceutical biotechnology• pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics• drug delivery/disposition and stability• pharmacognosy and phytopharmacy• pharmacology (clinical and animal)• toxicology• clinical pharmacy• pharmacovigilance• pharmaceutical and clinical biochemistry• pharmaceutical biology with genetics/pharmacogenomics/cell biology• pharmacoepidemiology/pharmacoeconomics/social pharmacy• physical pharmacy• radiopharmaceuticals• medicine (including diagnostics and therapy)• peptide and protein chemistry/protein design
【译文】Acta Pharmaceutica (AP) 是一本国际性的、科学的、多学科的期刊,致力于药学及相关科学,主要包含关于核心生物医学和健康主题的文章。AP 的目标是增加药学研究在学术界、工业和实验室中的影响力。AP 强调质量和原创性,从药物发现到临床实践,以初步报告、短篇通讯、原创研究论文和综述的形式发表报告。还发表书籍评论。AP 是一本每季度出版的、单盲同行评审的生物医药期刊,具有完全开放获取和“早鸟”平台。所有文章都经过严格的评估和公正的判断。AP 最重要的是科学诚信和正直。为了达到出版物伦理的最高标准,所有各方(作者、编辑、审稿人)都必须负责任和道德地行事。这意味着作者只能独家提交他们自己的新数据;新颖性和原创性是优先考虑的。此外,审稿人和编辑必须安全处理机密数据。AP 被列入多个世界顶级国际书目数据库,如 Clarivate Analytics 的 Web of Science® 核心收藏(SCI-Expanded、JCR/Science Edition 等)、EMBASE/Excerpta Medica、MEDLINE/PubMed、Scopus/SCImago 等。根据 SCImago JR,它是一份 Q2 期刊(药学科学),Clarivate JIF 值稳步增长,2022 年达到 2.8。涵盖的主题包括:• 药物设计• 分子建模/对接研究• 药物化学/药物化学• 药物代谢• 药物分析• 药物技术/制剂研究/纳米系统/化妆品学• 药物生物技术• 药剂学/生物药剂学(包括药代动力学)和药效学• 药物递送/分布和稳定性• 药用植物学和植物药• 药理学(临床和动物)• 毒理学• 临床药学• 药物警戒• 药物和临床生物化学• 药物生物学与遗传学/药理学基因组学/细胞生物学• 药物流行病学/药效学/社会药学• 物理药剂学• 放射性药物• 医学(包括诊断和治疗)• 肽和蛋白质化学/蛋白质设计

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |